| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | BPH GLOBAL LTD: Agreement to Develop Powdered Green Seaweed Kefir Additive | - | ASX | ||
| Do | BPH GLOBAL LTD: Update to Quarterly Activities Report | - | ASX | ||
| Do | BPH GLOBAL LTD: Testing Agreement Executed for Project Giddy-Up | - | ASX | ||
| 06.05. | BPH GLOBAL LTD: Binding MoU to Progress Development of Makassar Coastal Site | - | ASX | ||
| 30.04. | BPH GLOBAL LTD: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 28.04. | BPH GLOBAL LTD: Trading Results Rebound as Seasonal Conditions Improve | - | ASX | ||
| 27.04. | BPH GLOBAL LTD: Appointment of Chief Scientific Officer | - | ASX | ||
| BPH GLOBAL Aktie jetzt für 0€ handeln | |||||
| 24.04. | BPH GLOBAL LTD: Sale of China Birds Nest Business | - | ASX | ||
| 23.04. | BPH GLOBAL LTD: Development of Seaweed-based anti-aging supplement | - | ASX | ||
| 22.04. | BPH GLOBAL LTD: BPH Global Secures Coastal Site for Seaweed Cultivation | - | ASX | ||
| 20.04. | BPH GLOBAL LTD: BPH Global Launches New Investor Hub | - | ASX | ||
| 16.04. | BPH GLOBAL LTD: Notification of cessation of securities - BP8 | - | ASX | ||
| 31.03. | BPH GLOBAL LTD: Update on Seaweed-Based Bio-fertiliser & Bio-Stimulant | 1 | ASX | ||
| 26.03. | BPH GLOBAL LTD: Tenth Month Seaweed Trading Results | - | ASX | ||
| 18.03. | BPH GLOBAL LTD: Interim Update on Project Giddy-Up Development Progress | - | ASX | ||
| 16.03. | BPH GLOBAL LTD: Seaweed Biomass Expands Biofuel Opportunity | - | ASX | ||
| 16.03. | BPH GLOBAL LTD: Investor Presentation | - | ASX | ||
| 12.03. | BPH GLOBAL LTD: Shareholder Webinar Invitation | - | ASX | ||
| 26.02. | BPH GLOBAL LTD: Half Yearly Report and Accounts | 2 | ASX | ||
| 22.02. | BPH GLOBAL LTD: Ninth Month Seaweed Trading Results | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PAION | 0,072 | -25,13 % | XFRA MISTRADE ANTRAG IN ISIN DE000A3E5EG5 WURDE STATTGEGEBEN | Dem Mistrade-Antrag wurde stattgegeben. Folgende Geschaefte in der ISIN DE000A3E5EG5, Wertpapier-Name: PAION AG INH O.N., wurden aufgehoben:ISIN Datum Zeit Volumen PreisDE000A3E5EG5 02.02.2026 08:13:40 300 0... ► Artikel lesen | |
| EPIGENOMICS | 0,930 | 0,00 % | PTA-HV: Epigenomics AG: Einladung zur ordentlichen Hauptversammlung | DJ PTA-HV: Epigenomics AG: Einladung zur ordentlichen Hauptversammlung
Hauptversammlung gemäß -- 121 Abs. 4a AktG
Epigenomics AG: Einladung zur ordentlichen Hauptversammlung
Heidelberg... ► Artikel lesen | |
| CO.DON | 0,014 | -17,65 % | EQS-AFR: CO.DON AG i.l.: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: CO.DON AG i.l.
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
CO.DON AG i.l.: Vorabbekanntmachung über die... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 24.04.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.04.2026.ISIN NameCA46658Y1034 J2... ► Artikel lesen | |
| NUREXONE BIOLOGIC | 0,415 | +1,97 % | NurExone stärkt IP-Position mit australischem Patent | ||
| REPLENISH NUTRIENTS | 0,083 | -2,94 % | Replenish Nutrients Holding GAAP EPS of -$0.03, revenue of $2.96M | ||
| NEOVACS | 0,000 | +100,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.05.2026 | Das Instrument POH3 US14365C1036 CARNIVAL PLC ADR/1 DL1,66 EQUITY wird cum Kapitalmassnahme gehandelt am 06.05.2026 und ex Kapitalmassnahme am 07.05.2026 The instrument POH3 US14365C1036 CARNIVAL PLC... ► Artikel lesen | |
| NANOSPHERE HEALTH SCIENCES | 0,002 | 0,00 % | Nanosphere Health Sciences Inc (2): Nanosphere Health adopts semi-annual reporting | ||
| GENETIC TECHNOLOGIES | 0,034 | -100,00 % | GENETIC TECHNOLOGIES LIMITED: Long Term Suspended Entities | ||
| TRIVARX | - | - | TRIVARX LTD: March 2026 Quarterly Activities Report and Appendix 4C | ||
| RECCE PHARMACEUTICALS | 0,264 | 0,00 % | Recce Pharmaceuticals - Recce expands US government collaborations | Recce announced that it signed a second Cooperative Research and Development Agreement (CRADA) with the US Army. This new arrangement with the US Army Institute of Surgical Research (USAISR) will study... ► Artikel lesen | |
| CRISM THERAPEUTICS | - | - | Crism reports positive preclinical results from prostate cancer model | ||
| THX PHARMA | 3,405 | +3,50 % | THERANEXUS: THX Pharma Publishes Its 2025 Annual Results, Cash Position as of March 31, 2026, and Provides a Business Update | Lyon, France - April 28, 2026 - 7:00 p.m. CEST - THX Pharma (Theranexus), an innovative biopharmaceutical company specializing in the treatment of rare neurological diseases, today announces its... ► Artikel lesen | |
| PYC THERAPEUTICS | - | - | PYC THERAPEUTICS LIMITED: Investor Webinar | ||
| PATRYS | - | - | PATRYS LIMITED: Letter to Shareholders - General Meeting |